Skip to content

A clinical trial to compare the clinical, metabolic and hormonal parameters amongst the women who respond to the ovulation induction drug clomiphene citrate and those who do not.

Comparison of clinical, metabolic and hormonal parameters among Clomiphene Citrate sensitive and Clomiphene Citrate resistant PCOS women.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/03/012640
Enrollment
164
Registered
2018-03-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- PCOS related infertility

Interventions

None listed

Sponsors

PGIMER Chandigarh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Women with PCOS related infertility based on Rotterdamâ??s criteria. 2. Age less than 40 yrs. 3. Normal serum prolactin and thyroid function tests.

Exclusion criteria

Exclusion criteria: 1. Patient is on any insulin-sensitizing agent or any lipid-lowering agent or any other drugs 2. Presence of any other endocrine disorder 3. Presence of anorexia nervosa or bulimia nervosa or any hypothalamic or pituitary dysfunction.

Design outcomes

Primary

MeasureTime frame
Ovulation with Clomiphene CitrateTimepoint: At day 10-11 of each cycle, trans-vaginal ultrasound done to look for the formation of dominant follicle. This is repeated for three consecutive cycles after ovulation induction with 50 mg, 100 mg and 150 mg clomiphene citrate.

Secondary

MeasureTime frame
1. Dose at which ovulation occurred. (50 mg/100 mg/150 mg) 2.Dose at which conception occurred. (50 mg/100 mg/150 mg). 3. Comparison between different PCOS phenotypes.Timepoint: 1. Transvaginal scan done on day 10-11 of each cycle to look for the formation of the dominant follicle after ovulation induction with 50 mg/ 100 mg/150 mg Clomiphene Citrate. 2. Conception recorded with urine pregnancy test or ultrasound during this period of 3 months.

Countries

India

Contacts

Public ContactGarima Sachdeva

PGIMER, CHANDIGARH

sgainder@gmail.com8284848774

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026